neither retatrutide nor Lipo C is commissioned by the NHS
Evidence and NHS Treatments Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK exclusively for type 2 diabetes management, not for endometriosis treatment
- Duration: Use until desired tanning is achieved, then maintenance dosing as needed (e.g., 1 mg per week)
In some cases, combining intermittent fasting with GLP-1 therapy can be appropriatewhen its medically supervised
[DOI] [PubMed] [Google Scholar] 53.Jhund P.S., Solomon S.D., Docherty K.F., Heerspink H.J.L., Anand I.S., Bhm M., Chopra V., de Boer R.A., Desai A.S., Ge J., et al
This paper provides evidence of increased incomplete -oxidation of lipids in states of insulin resistance and obesity, resulting in the accumulation of acylcarnitines